晕康胶囊治疗椎基底动脉供血不足性眩晕临床观察  

Clinical Observation of Treating the Vertigo Caused by Vertebrobasilar Insufficiency with YunKang Capsule

作　　者：蒋清林 李作孝[2] 

机构地区：[1]邵阳市中心医院内一科,湖南邵阳422000 [2]泸州医学院附属医院神经内科,四川泸州646000

出　　处：《辽宁中医药大学学报》2009年第3期85-87,共3页Journal of Liaoning University of Traditional Chinese Medicine

摘　　要：目的:观察晕康胶囊治疗椎基底动脉供血不足(VBI)性眩晕的临床疗效。方法:将VBI性眩晕患者115例,随机分成晕康治疗组60例和常规治疗组55例;另设正常对照组60例。晕康治疗组给予复方丹参片+氟桂利嗪+晕康胶囊口服:复方丹参片每次口服2片,每天3次;氟桂利嗪每次口服5mg,每晚1次;晕康胶囊每次口服3颗,每天3次。常规治疗组给予复方丹参片+氟桂利嗪口服,用法同前。以上两治疗组2周为1个疗程,连续观察1个月。疗程结束后比较晕康治疗组和常规治疗组总体疗效,经颅多普勒(TCD)前后检查结果。结果:(1)晕康治疗组治疗后主要症状(眩晕)有效率96.6%,而常规治疗组为85.4%,两组比较有显著性差异(P<0.05)。从临床疗效来看晕康治疗组显效率为69.99%、总有效率为91.7%;常规治疗组显效率为30.9%、总有效率为72.73%,晕康治疗组疗效明显优于常规治疗组。(2)晕康治疗组治疗后椎动脉、基底动脉收缩期峰值血流速度(Vs)、平均流速(Vm)、搏动指数(PI)均较治疗前有所改善,改善程度优于治疗后常规治疗组(P<0.05)。结论:晕康胶囊治疗椎基底动脉供血不足所致眩晕有良好临床疗效。Objective:To observe the effect of YunKang Capsule(YKC)on treating the vertigo caused by vertebrobasilar insufficiency(VBI). Methods:115 patients of VBI vertigo which are stochastically divided into the YKC therapy group 60 examples and the conventional therapy group 55 examples. The normal control group 60 examples are supposed in addition. The YKC therapy group is given compound Dansheng pellets and Flunarizine tablets and YKCs to take orally: compound Dansheng pellets, 2 pellets a time and three times a ...

关 键 词：晕康胶囊 椎基底动脉供血不足 眩晕 经颅多普勒 

分 类 号：R255.3[医药卫生—中医内科学]